Stig Hansen, Carmot Therapeutics co-founder and CEO

RA Cap­i­tal jumps on board di­a­betes biotech, pitch­ing in on $160M Se­ries D

A small Cal­i­for­nia biotech is back with more cash and a new big name VC to work with.

Car­mot Ther­a­peu­tics re­port­ed a Se­ries D fi­nanc­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.